Dr. Thomas Carr is a patent agent in the Intellectual Property practice group in the firm's Washington, D.C. office.
Areas of Practice
Dr. Carr assists attorneys with both patent prosecution and patent litigation in the chemical, molecular biology, and pharmaceutical areas.
During his time at Sheppard Mullin, Dr. Carr has provided litigation support to Hatch-Waxman cases as well as a patent infringement case between competitor biopharmaceutical companies involving patents relating to gene therapy. Dr. Carr also has worked on patent prosecution matters involving pharmaceuticals, nutraceuticals, dermatological compositions, methods of treatment, and medical devices. Dr. Carr has also assisted with drafting licensing agreements.
During his tenure at the University of Delaware, Dr. Carr wrote his dissertation on “Expanding the Avian Micro RNA Repertoire of Domesticated Poultry and Investigating the NLRP3 Inflammasome Messenger RNA and Micro RNA Transcriptomes in Anas Platyrhynchos (Ducks).” Dr. Carr’s research involved miRNA characterization, investigating the avian upper respiratory viral microbiome, and developing sequencing pipelines using open source software for DNA, RNA, and miRNA transcriptomes. Furthermore, Dr. Carr taught introductory Biology laboratory courses during most of his graduate tenure, which included participation in the Interdisciplinary Science and Engineering lab integration into the University’s curriculum through merged Biology and Chemistry labs. Dr. Carr’s areas of scientific experience include biochemistry, bioinformatics, computational biology, genetics, molecular biology, and virology.
During his tenure at Widener University, Dr. Carr wrote a senior thesis on “Early Splicing Factors Influence Triglyceride Levels in Drosophila Melanogaster (Fruit Fly).” Dr. Carr’s research involved investigating factors contributing to disease phenotypes and developing quantitative assays. Dr. Carr presented his undergraduate research at various national venues including: Society-for-Developmental-Biology; National Drosophila Research Conference; Sigma Xi Annual Meeting and Student Research Conference; and National Conference on Undergraduate Research.
J.D., Intellectual Property Law Concentration, Antonin Scalia Law School at George Mason University, 2020
Ph.D., Molecular Biology & Genetics, University of Delaware, 2017
B.S., Biochemistry, Widener University, 2010
- U.S. Patent and Trademark Office